U.S. Hospitality Stock News

MoonLake Immunotherapeutics (MLTX) is back in the spotlight after disclosing that lead drug candidate sonelokimab fell short of a rival treatment in Phase 3 trials, triggering lawsuits and a brutal repricing of the stock. See our latest analysis for MoonLake Immunotherapeutics. The latest bounce to a share price of $14.79, reflected in a 1 month share price return of 15.82 percent, comes after a brutal 90 day share price collapse of 72.24 percent and a 1 year total shareholder return of...

In recent weeks, Waste Management has seen improving sentiment as analysts raised earnings estimates and projected year-over-year growth ahead of its upcoming results. Behind this optimism lies a view that the company’s near-term business health and profitability could strengthen, even as it contends with rising capital needs and margin pressures. We’ll now examine how this analyst optimism ahead of earnings might influence Waste Management’s investment narrative built around...

Earlier this month, Exponent, Inc. reported third-quarter revenues that grew 9.6% year on year and exceeded analyst expectations by 4%, crediting its diversified portfolio and broad industry reach. This performance marked the strongest analyst estimates beat among its peer group, underlining how Exponent’s cross-sector expertise is translating into resilient demand. Next, we’ll examine how Exponent’s double-digit net revenue growth and broad-based demand may influence its existing investment...

Citigroup Downgrade Puts Fresh Scrutiny on Seadrill Citigroup's move to cut Seadrill (NYSE:SDRL) from Buy to Neutral, while trimming its outlook, has put fresh attention on a stock already down about 19% this year, despite improving fundamentals. See our latest analysis for Seadrill. The downgrade lands after a choppy run for Seadrill, with a roughly 5.6% 1 month share price return failing to offset a near 19% year to date share price decline. The 3 year total shareholder return remains...

Renewed analyst optimism around Allot (ALLT), highlighted by its Zacks Rank of #1 Strong Buy and a sharply upgraded earnings outlook over the past 3 months, has pushed the stock sharply ahead of its tech peers. See our latest analysis for Allot. The optimism seems to be feeding directly into the tape, with Allot’s share price at $9.86 after a robust year to date share price return of around 59 percent and a standout 1 year total shareholder return of roughly 87 percent. This suggests momentum...

Recently, analysts upgraded NNN REIT on the back of its resilient triple-net retail portfolio, expectations for occupancy above 98% by year-end, and record-paced acquisition plans supported by about US$1.40 billion in liquidity and a BBB+ credit rating. An interesting angle is how NNN REIT’s rapid tenant turnarounds and consistent dividend growth record are reinforcing confidence in its ability to manage retail-sector risks while expanding its portfolio. We’ll now explore how this improved...

Earlier this month, Instacart announced it became the first grocery partner to launch an end-to-end shopping app on ChatGPT and separately expanded its same-day delivery offering through a new partnership with The Home Depot Canada across more than 175 stores. Together, these moves highlight how Instacart is using AI-driven customer experiences and broader retailer coverage, including big and bulky items, to deepen its role in everyday household and home improvement purchasing. We’ll now...

AutoZone, Inc. has reported past first-quarter 2025 results, with sales rising to US$4,628.63 million while net income and earnings per share declined year over year. The combination of higher revenue but lower profitability, alongside management’s commitment to opening more locations, highlights both growth ambition and cost pressures. We’ll now examine how AutoZone’s higher sales but softer earnings shape its investment narrative and the outlook for continued store expansion. Rare earth...

Insider selling puts fresh focus on Cogent Communications Holdings Cogent Communications Holdings (CCOI) is back on investors radar after Chief Financial Officer Thaddeus Weed sold 7,300 shares on December 11, extending a year long pattern of insider selling without any offsetting purchases. See our latest analysis for Cogent Communications Holdings. The latest CFO sale lands against a volatile backdrop. Cogent’s 7 day share price return of 18.6 percent and 30 day share price return of 32.6...

Oshkosh (OSK) has been quietly rewarding patient investors, with the stock climbing about 6% over the past month and more than 40% year to date, driven by solid revenue and earnings growth. See our latest analysis for Oshkosh. That momentum is not a flash in the pan. Oshkosh has delivered a robust year to date share price return, while a solid one year total shareholder return suggests investors are increasingly pricing in its earnings traction and defense exposure rather than backing...

On December 4, 2025, First Busey increased its equity buyback authorization by 4,000,000 shares, bringing the total program to 11,666,667 shares. This expanded repurchase capacity highlights management’s willingness to return capital to shareholders and may signal confidence in the company’s underlying fundamentals. Next, we’ll explore how this enlarged buyback program shapes First Busey’s investment narrative, especially its approach to shareholder returns and capital allocation. Rare earth...

Recently, UBS maintained its Neutral rating on Peabody Energy while lifting its outlook on the coal producer’s prospects across its seaborne thermal and metallurgical segments. This shift in analyst sentiment highlights how Peabody’s positioning in both power and steel-related coal markets is increasingly shaping investor expectations. We’ll now explore how this improved analyst confidence in Peabody’s coal portfolio influences the company’s existing investment narrative. This technology...

Aflac (AFL) just expanded its public sector reach by naming Ameriflex as its new administrative partner for spending accounts, giving investors a fresh angle on the stock's growth and service capabilities. See our latest analysis for Aflac. The Ameriflex deal slots neatly into a steady year for Aflac, with the share price at $110.05 and a solid year to date share price return of 7.51 percent. A robust five year total shareholder return of 181.67 percent suggests longer term momentum remains...

U.S. Bancorp’s board has declared a regular quarterly dividend of US$0.52 per common share, and a series of quarterly dividends across its preferred stock classes, all payable on January 15, 2026, to shareholders of record as of December 31, 2025. Together with earlier announcements of a higher quarterly dividend and a multibillion‑dollar share repurchase authorization, these payouts highlight how U.S. Bancorp is currently using its capital strength to reward both common and preferred...

Rapport Therapeutics (RAPP) just put RAP-219 squarely on investors radar, unveiling detailed Phase 2a epilepsy data at the American Epilepsy Society meeting that backs up earlier efficacy signals and clarifies the path toward pivotal Phase 3 trials. See our latest analysis for Rapport Therapeutics. The latest RAP-219 update lands on top of already strong momentum, with a roughly 24 percent 1 month share price return and a year to date share price return of about 65 percent. This suggests...

Morgan Stanley’s new Overweight rating on Solaris Energy Infrastructure (SEI), together with recent target bumps from Piper Sandler and Barclays, puts fresh attention on how this data center power specialist might perform through 2028. See our latest analysis for Solaris Energy Infrastructure. The upbeat analyst coverage lands just as SEI cools off from a sharp run, with a 1 day share price return of negative 14.81 percent following a 90 day share price return of 43.07 percent and a powerful...

In recent days, United Rentals has drawn fresh attention as analysts at firms including Morgan Stanley and Citigroup reaffirmed positive views, while the company completed a US$1.50 billion senior notes offering and expanded internationally through the acquisition of Australian rental business Alfasi Hire. Together with a high GF Score of 95 out of 100 and an 18.45% operating margin increase over five years, these moves highlight how United Rentals is reinforcing its position as a...

Comerica (CMA) is back on investors radar after upbeat quarterly results coincided with its Q4 2025 Small Business Pulse Index, which shows strong client optimism and new plans for capital spending that could support lending activity. See our latest analysis for Comerica. That optimism is showing up in the price action too, with Comerica’s share price up sharply over the past quarter and a strong year to date share price return suggesting momentum is building, while a solid multi year total...

Agree Realty (ADC) just gave income focused investors something to chew on, as the board signed off on a 3.6% bump to its monthly common dividend, signaling steady confidence in the REIT’s cash flows. See our latest analysis for Agree Realty. Even with this dividend bump, Agree Realty’s share price at $71.75 has delivered only modest upside. The 1 year total shareholder return is roughly flat, while the 5 year total shareholder return is about 39%. This suggests that long term compounding...

In early December 2025, Trinity Industries, Inc. raised its quarterly dividend on common stock to US$0.31 per share, marking its 247th consecutive dividend payment and seventh straight annual increase, while also participating in the Goldman Sachs Industrials and Materials Conference 2025. This long-running pattern of dividend growth highlights Trinity’s emphasis on consistent cash returns to shareholders, adding an extra dimension to how investors may assess its railcar-focused business...

Equifax (EFX) just rolled out Income Qualify, a mortgage tool that gives lenders earlier access to verified income and employment data. The goal is to streamline prequalification while tightening risk controls in a still cautious housing market. See our latest analysis for Equifax. The launch of Income Qualify fits into a broader push to monetize Equifax’s data assets, and the market seems cautiously constructive. A 7 day share price return of 4.41 percent and a 30 day share price return of...

Western Alliance Bancorporation recently appointed cybersecurity expert Dr. Michael Papay and veteran risk executive Clarke Starnes III to its Board as the bank approaches the US$100 billion asset threshold and prepares for Large Financial Institution status. These additions bring deep experience in technology risk, cybersecurity, and enterprise risk management, which may prove important as Western Alliance faces higher regulatory expectations and more complex operational risks. Next, we’ll...

If you are wondering whether Palantir Technologies is still a smart buy after its huge run, or if most of the upside is already priced in, you are not alone. The stock has climbed 1.0% over the last week, 5.5% over the past month, and an eye catching 144.1% year to date, with a 141.3% gain over the last year and an extraordinary 2560.4% rise over three years, putting it firmly on growth investors’ radar. Recently, Palantir has stayed in the spotlight as governments and large enterprises...

ImmunityBio previously announced that the European Medicines Agency had recommended granting a conditional EU marketing authorization for ANKTIVA, in combination with BCG, to treat BCG-unresponsive non-muscle invasive bladder cancer carcinoma in situ based on a single-arm trial in 100 adults. This marks the first EMA-recommended immunotherapy for this form of bladder cancer that activates NK cells, T cells, and memory T cells, potentially offering an alternative to radical surgery for...